This week has served as a stark reminder of how much evolution is left to do in the health and life sciences ecosystem. On the one hand, we are coming into a time of real investment via the federal economic stimulus package that for the first time places health IT fully into focus. On the other hand, we are facing massive job losses across all markets, but especially in the pharmaceutical business where thousands of people have already lost their jobs, and likely more to follow. How real and valuable is the change we are seeing?
Continue reading “Workplace Ups and Downs”
